Connect Biopharma Holdings Limited CNTB
0.77 USD 0.00 (-0.39%)
At closeNov 4, 2026, 8:24 AM EST
0.88 +0.10 +13.03%
Pre-market · Nov 4, 8:24 AM ET
0.7685 Day range 0.7949
0.732 52-week range 3.82
- YTD
- -72.55%
- 1 year
- -53.08%
Financial health
Altman Z-Score
-15.62 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -2.8×
FY 2018 5y median -1.1× FY 2025
P/S 2453×
FY 2018 5y median 0.0× FY 2025
P/B 3.7×
FY 2018 5y median 0.8× FY 2025
P/FCF -3.0×
FY 2018 5y median -2.9× FY 2025
EV/EBITDA -2.2×
FY 2018 5y median 0.1× FY 2025
EV/Sales 1864×
FY 2018 5y median 0.0× FY 2025
FCF Yield -32.9%
FY 2018 5y median -34.6% FY 2025
Profitability
Gross Margin 100.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin -90740.6%
FY 2018 5y median 0.0% FY 2025
Net Margin -86687.5%
FY 2018 5y median 0.0% FY 2025
ROE -132.2%
FY 2018 5y median -74.3% FY 2025
ROIC -135.7%
FY 2018 5y median -67.5% FY 2025
ROA -98.9%
FY 2018 5y median -67.9% FY 2025
Growth (YoY)
Revenue -99.8%
FY 2018 FY 2025
Operating Income -158.7%
FY 2018 FY 2025
EPS (diluted) -257.1%
FY 2018 FY 2025
Free Cash Flow -112.0%
FY 2018 FY 2025
Financial Health
Current Ratio 3.7×
FY 2018 5y median 10.0× FY 2025
Quick Ratio 3.7×
FY 2018 5y median 10.0× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2018 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
